Trial reportBioMed research international2020
Clinical Characteristics and Surgical Management of Gastrointestinal Schwannomas.
Trial report in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 17 citations in OpenAlex.
- Perforated gastric schwannoma treated with laparoscopic wedge gastrectomy: a rare case report.International journal of surgery case reports · 2026Article
- Management of Gastrointestinal Schwannomas: A State-of-the-Art Review.Journal of gastrointestinal cancer · 2026Review
- Clinical characteristics and endoscopic management of upper gastrointestinal schwannoma: 12-year experience from a large tertiary hospital in China.Surgical endoscopy · 2026Article
- Research progress on the application of dual energy CT in gastric diseases.Frontiers in medicine · 2026Review
- Gastric schwannoma with atypical manifestations in an adult patient: case report and literature review.Ecancermedicalscience · 2025Article
- Gastric Schwannoma: A Rare Cause of Gastric Bleeding.Journal of medical cases · 2024Article
- Ileal Schwannoma: A Rare Cause of Pelvic Mass.Case reports in surgery · 2024Article
- Laparoscopic resection for gastric schwannoma larger than 30 mm with long-term outcomes.BMC surgery · 2023Article
- Development of a CT image analysis-based scoring system to differentiate gastric schwannomas from gastrointestinal stromal tumors.Frontiers in oncology · 2023Article
- Differentiating gastric schwannoma from gastric stromal tumor (≤5 cm) by histogram analysis based on iodine-based material decomposition images: a preliminary study.Frontiers in oncology · 2023Article
- Review
- Gastric leiomyoma or gastric schwannoma: a diagnostic dilemma and the role of laparoscopic surgery.BMJ case reports · 2022Article
- Review
- Clinicopathological characteristics of gastrointestinal schwannomas: A retrospective analysis of 78 cases.Frontiers in oncology · 2022Article
- A radiologic diagnostic scoring model based on CT features for differentiating gastric schwannoma from gastric gastrointestinal stromal tumors.American journal of cancer research · 2022Article
- Gastric schwannoma treated by endoscopic full-thickness resection and endoscopic purse-string suture: A case report.World journal of gastroenterology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesSchwannomas are tumors arising from Schwan cells of the neural sheath. Gastrointestinal schwannomas (GS) are rare and easily confused with a heterogeneous group of neuroectodermal or mesenchymal neoplasms. The aim of the present study is to analyze the clinicopathological features, surgical management methods, and long-term prognoses of GS patients.
methodsBetween August 2004 and July 2019, 51 patients with GS were treated at the Peking Union Medical College Hospital. The medical records were reviewed retrospectively. A database containing demographic characteristics, clinical symptoms, imaging tests, operation details, pathological results, and prognoses was constructed and analyzed.
resultsGS accounted for 2.0% of all schwannomas. The cohort comprised 19 men (37.3%) and 32 women (62.7%). The mean age was 55.7 ± 11.4 years. The most common symptom was abdominal pain (29.4%). Twenty-seven patients (52.9%) were asymptomatic and diagnosed incidentally. The most common tumor location of GS was the stomach (90.2%). S-100 had the highest positive rate (100%) in immunohistochemical staining. Forty-six patients (90.2%) were followed-up at a mean period of 49.5 ± 41.4 months. Forty-four patients (95.7%) survived without tumor, 1 patient survived with tumor, and 1 patient died. The 5-year cumulative overall survival rate and cumulative disease-free survival rate were 97.5% and 95.2%, respectively.
conclusionGS are rare gastrointestinal tumors with favorable prognoses after surgical resection. Stomach is the most common site. Definitive diagnosis is determined by postoperative pathology. S-100 expression has diagnostic significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.